|
1
|
Omenn GS, Goodman GE, Thornquist MD,
Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B,
Williams JH Jr, Barnhart S, Cherniack MG, Brodkin CA and Hammar S:
Risk factors for lung cancer and for intervention effects in CARET,
the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst.
88:1550–1559. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Paolini M, Cantelli-Forti G, Perocco P,
Pedulli GF, Abdel-Rahman SZ and Legator MS: Co-carcinogenic effect
of beta-carotene. Nature. 398:760–761. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guengerich FP: Cytochrome P450: what have
we learned and what are the future issues? Drug Metab Rev.
36:159–197. 2004. View Article : Google Scholar
|
|
4
|
Nebert DW, Wikvall K and Miller WL: Human
cytochromes P450 in health and disease. Philos Trans R Soc Lond B
Biol Sci. 368:201204312013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang JY, Wang Y and Prakash C:
Xenobiotic-metabolizing enzymes in human lung. Curr Drug Metab.
7:939–948. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shimada T: Xenobiotic-metabolizing enzymes
involved in activation and detoxification of carcinogenic
polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet.
21:257–276. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shimada T and Fujii-Kuriyama Y: Metabolic
activation of polycyclic aromatic hydrocarbons to carcinogens by
cytochromes P450 1A1 and 1B1. Cancer Sci. 95:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma Q and Lu AY: CYP1A induction and human
risk assessment: an evolving tale of in vitro and in vivo studies.
Drug Metab Dispos. 35:1009–1016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kamdem LK, Meineke I, Gödtel-Armbrust U,
Brokmöller J and Wojnowski L: Dominant contribution of P450 3A4 to
the hepatic carcinogenic activation of aflatoxin B1. Chem Res of
Toxicol. 19:577–586. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou SF, Xue CC, Yu XQ and Wang G:
Metabolic activation of herbal and dietary constituents and its
clinical and toxicological implications: an update. Curr Drug
Metab. 8:526–553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ohno M, Darwish WS, Ikenaka Y, Miki W and
Ishizuka M: Astaxanthin can alter CYP1A-dependent activities via
two different mechanisms: induction of protein expression and
inhibition of NADPH P450 reductase dependent electron transfer.
Food Chem Toxicol. 49:285–1291. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gradelet S, Astorg P, Pineau T, Canivenc
MC, Siess MH, Leclerc J and Lesca P: Ah receptor-dependent CYP1A
induction by two carotenoids, canthaxanthin and b-apo-8′-carotenal,
with no affinity for the TCDD binding site. Biochem Pharmacol.
54:307–315. 1997.PubMed/NCBI
|
|
13
|
Breinholt V, Lauridsen ST, Daneshvar B and
Jakobsen J: Dose-response effects of lycopene on selected
drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett.
154:201–210. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Astorg P, Gradelet S, Leclerc J and Siess
MH: Effects of provitamin A or non-provitamin A carotenoids on
liver xenobiotic-metabolizing enzymes in mice. Nutr Cancer.
27:245–249. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu CL, Lim YP and Hu ML: Fucoxanthin
attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and
multiple drug resistance 1 (MDR1) gene expression through pregnane
X receptor (PXR)-mediated pathways in human hepatoma HepG2 and
colon adenocarcinoma LS174T cells. Mar Drugs. 10:242–257. 2012.
View Article : Google Scholar
|
|
16
|
Firdous AP, Sindhu ER, Ramnath V and
Kuttan R: Anti-mutagenic and anti-carcinogenic potential of the
carotenoid meso-zeaxanthin. Asian Pac J Cancer Prev. 11:1795–1800.
2010.PubMed/NCBI
|
|
17
|
Wang H and Leung LK: The carotenoid
lycopene differentially regulates phase I and II enzymes in
dimethylbenz[a]anthracene-induced MCF-7 cells. Nutrition.
26:1181–1187. 2010.PubMed/NCBI
|
|
18
|
Gradelet S, Astorg P, Le Bon AM, Bergès R
and Suschetet M: Modulation of aflatoxin B1 carcinogenicity,
genotoxicity and metabolism in rat liver by dietary carotenoids:
evidence for a protective effect of CYP1A inducers. Cancer Lett.
114:221–223. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim KN, Ahn G, Heo SJ, Kang SM, Kang MC,
Yang HM, Kim D, Roh SW, Kim SK, Jeon BT, Park PJ, Jung WK and Jeon
YJ: Inhibition of tumor growth in vitro and in vivo by fucoxanthin
against melanoma B16F10 cells. Environ Toxicol Pharmacol. 35:39–46.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu RX, Hu XM, Xu SQ, Jiang ZJ and Yang W:
Effects of fucoxanthin on proliferation and apoptosis in human
gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway.
Eur J Pharmacol. 657:10–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Chen S, Xu S, Yu X, Ma D, Hu X and
Cao X: In vivo induction of apoptosis by fucoxanthin, a marine
carotenoid, associated with down-regulating STAT3/EGFR signaling in
sarcoma 180 (S180) xenografts-bearing mice. Mar Drug. 10:2055–2068.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim JM, Araki S, Kim DJ, Park CB, Takasuka
N, Baba-Toriyama H, Ota T, Nir Z, Khachik F, Shimidzu N, Tanaka Y,
Osawa T, Uraji T, Murakoshi M, Nishino H and Tsuda H:
Chemopreventive effects of carotenoids and curcumins on mouse colon
carcinogenesis after 1,2-dimethyhydrazine initiation.
Carcinogenesis. 19:81–85. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okuzumi J, Takahashi T, Yamane T, Kitao Y,
Inagake M, Ohya K, Nishino H and Tanaka Y: Inhibitory effects of
fucoxanthin, a natural carotenoid, on
N-ethyl-N′-nitro-N-nitrosoguanidine-induced mouse duodenal
carcinogenesis. Cancer Lett. 68:159–168. 1993.PubMed/NCBI
|
|
24
|
Ciolino HP, MacDonald CJ and Yeh GC:
Inhibition of carcinogen-activating enzymes by
16alpha-fluoro-5-androsten-17-one. Cancer Res. 62:3685–3690.
2002.PubMed/NCBI
|
|
25
|
Goralczyk R: Beta-carotene and lung cancer
in smokers: review of hypotheses and status of research. Nutr
Cancer. 61:767–774. 2009. View Article : Google Scholar : PubMed/NCBI
|
